Person: KEPENEKLİ KADAYİFCİ, EDA
Loading...
Email Address
Birth Date
Research Projects
Organizational Units
Job Title
Last Name
KEPENEKLİ KADAYİFCİ
First Name
EDA
Name
18 results
Search Results
Now showing 1 - 10 of 18
Publication Open Access Effect of video camera monitoring feedback on hand hygiene compliance in neonatal intensive care unit, an interventional study(2023-01-02) SİLİ, ULUHAN; MEMİŞOĞLU, ASLI; ÖZEK, EREN; KEPENEKLİ KADAYİFCİ, EDA; Bilgin H., SİLİ U., Pazar N., Kucuker I., Kepenekli E., Yanar M. A., MEMİŞOĞLU A., ÖZEK E., Adhikari N. K., Pinto R., et al.Background: The purpose of this study was to determine whether use of a video camera surveillance system for hand hygiene (HH) monitoring, video-based education, and feedback could improve the HH compliance in a neonatal intensive care unit (NICU). Methods and materials: This was an interventional before-after trial conducted in a level-III NICU between July 2019 and June 2020. HH compliance was measured using randomly selected video-camera footage in the baseline, intervention, and maintenance periods. After the baseline, an intervention consisting of feedback and education with video scenarios was implemented. The primary outcome was change in HH compliance. The compliance rates were analyzed as an interrupted time series (ITS) with a segmented regression model adjusted for autocorrelation for each study period. Results: We identified a total of 8335 HH indications. There were non significant increases in the total compliance rate (9.0%, 95% CI -2% to 20%) at the time of intervention and in the compliance rate after intervention (0.26%, 95% CI -0.31% to 0.84%) per day. The hand hygiene compliance before patient contact significantly increased (19.8%, 95% CI, 4.8%-34.8%). Incorrect glove use improved non-significantly with the intervention (-3.4%, 95% CI -13.4% to 6.7%). Conclusion: In this study of HH monitoring using video-camera footage combined with an intervention including feedback and education, there were inconsistent improvements in HH compliance. However, these improvements were not sustained in the long term. Frequent feedback and education may be required to sustain high compliance.Publication Metadata only Ev içi temaslı beş çocuk olguda çoklu ilaca dirençli tüberkülozun yönetimi(2022-03-17) ERDEM ERALP, ELA; GÖKDEMİR, YASEMİN; KEPENEKLİ KADAYİFCİ, EDA; Parlak B., Yılmaz D., Ergenç Z., Yılmaz S., Aslan S., Babalık A., Erdem Eralp E., Gökdemir Y., Kepenekli Kadayifci E.Publication Open Access Healthcare-associated staphylococcus aureus infections in children in Turkey: A six-year retrospective, single-center study(2023-08-01) İLKİ, ZEYNEP ARZU; KEPENEKLİ KADAYİFCİ, EDA; Yakut N., Ergenç Z., Tuncay S. A., Bayraktar S., Sayın E., İlki Z. A., Kepenekli Kadayifci E.Objective: To describe clinical and epidemiological characteristics, antimicrobial susceptibility and mortality-associated factors of healthcare-associated infections (HCAIs) caused by Staphylococcus (S.) aureus in children. Methods: We conducted a retrospective, single-centre study of pediatric HCAIs caused by S. aureus from a tertiary care hospital in Turkey between February 2014 and December 2019. The clinical and epidemiological characteristics and antimicrobial susceptibility of the methicillin-susceptible and methicillin-resistant S. aureus (MSSA and MRSA) isolates was evaluated. Results: A total of 310 pediatric patients were examined. Overall, 225 (72.6%) isolates were MSSA and 85 (27.4%) were MRSA. All S. aureus isolates were susceptible to teicoplanin, vancomycin, linezolid, tigecycline, mupirocin, and daptomycin. Penicillin resistance rates were high (89.0%), while fosfomycin, gentamicin, and clindamycin resistance rates were low (1.3%, 1.0%, and 2.3%, respectively). Except susceptibility to fosfomycin, which was significantly lower in 2014 compared to 2018 and 2019, no significant difference was found in the antimicrobial susceptibility of S. aureus isolates between the years. Baseline characteristics and mortality rate were similar comparing MRSA and MSSA causing HCAIs. The mortality rate of HCAIs caused by S. aureus was 6.5% (20 patients). Malignancy was an independent risk factor associated with mortality in the multivariate analysis (OR 5.446, 95% CI 1.573- 18.849). Conclusions: Our findings demonstrate that MSSA remained the most causative agent of HCAIs caused by S. aureus. The mortality rate was 6.5%, the antibiotic resistance rate was quite high for penicillin and diagnosis of malignancy was the main risk factor for increasing mortality in children. These findings could help improve the management of HCAIs caused by S. aureus in children.Publication Metadata only The role of human bocavirus on respiratory tract infections in children(2023-05-08) İLKİ, ZEYNEP ARZU; ÜLGER, NURVER; KEPENEKLİ KADAYİFCİ, EDA; Aslan Tuncay S., Ergan B., Ergenç Z., Yılmaz S., Parlak B., Canizci Erdem P., Dizi Işık A., İlki Z. A., Ülger N., Kepenekli Kadayifci E.Publication Metadata only Kronik granülomatöz hastalıklı olgularda küf ilişkili invaziv enfeksiyonlar: Tek merkez deneyimi(2022-03-17) AYDINER, ELİF; KEPENEKLİ KADAYİFCİ, EDA; ÖZEN, AHMET OĞUZHAN; BARIŞ, SAFA; Ergenç Z., Bilgiç Ertan S., Barış S., Aydıner E., Özen A. O., Aslan S., Yılmaz S., Parlak B., Kepenekli Kadayifci E.Publication Open Access Successful treatment of fasciola hepatica with metronidazole in a child: A case report(2022-11-01) KEPENEKLİ KADAYİFCİ, EDA; YAPICI, ÖZGE; BATU, UTKU; TUTAR, ENGİN; Ergenç Z., Kepenekli Kadayifci E., Yakut N., Yapıcı Ö., Batu U., Tutar E.Fasciola hepatica is a zoonotic liver trematode that usually causes infection in cattle and sheep, and is transmitted to humans by consuming water and aquatic plants contaminated with metacercaria. The detection of Fasciola eggs in stools, serological evaluation and radiological evaluation are essential for diagnosis. Triclabendazole is the first-line therapy for fascioliasis. However, as triclabendazole is not an easily accessible drug in countries such as Turkey, it reveals a quest for alternative therapies. In this report, we present a 10-year-old boy with fascioliasis successfully treated with a course of metronidazole 1.5 g/ day for 3 weeks in 2020. During the follow-up, eosinophilia and radiological findings completely recovered. Here we report a case of pediatric fascioliasis that was cured with metronidazole successfully.Publication Metadata only Dalak enfarktı ile komplike bruselloz vakası(2022-03-17) KEPENEKLİ KADAYİFCİ, EDA; Yılmaz S., Aslan S., Ergenç Z., Parlak B., Kepenekli Kadayifci E.Publication Metadata only Çocuklarda staphylococcus aureus kaynaklı sağlık bakımı ilişkili enfeksiyonlar: Antimikrobiyal duyarlılık ve mortalite: Altı yıllık tek merkez deneyimi(2023-03-16) KEPENEKLİ KADAYİFCİ, EDA; İLKİ, ZEYNEP ARZU; Yakut N., Ergenç Z., Tuncay S. A., Bayraktar S., Sayın E., İlki Z. A., Kepenekli Kadayifci E.Publication Metadata only Tedaviye dirençli giardiazisli X'e bağlı agamaglobulinemi olgusunda başarılı tedavi(2021-10-06) KEPENEKLİ KADAYİFCİ, EDA; BARIŞ, SAFA; ÖZEN, AHMET OĞUZHAN; Babayeva R., Bilgiç Eltan S., Ergenç Z., Kepenekli Kadayifci E., Sefer A. P., Kolukısa B., Yalçın Güngören E., Aydıner E., Barış S., Özen A. O.Publication Metadata only İnsan bokavirüs enfeksiyonu ilişkili ensefalit olgusu(2022-03-17) ÖZTÜRK THOMAS, GÜLTEN; AKBEYAZ, İSMAİL HAKKI; KEPENEKLİ KADAYİFCİ, EDA; YAPICI, ÖZGE; Aslan S., Ergenç Z., Yılmaz S., Parlak B., Akkurt V., Varol F., Öztürk G., Akbeyaz İ. H., Yapıcı Ö., Almus E., et al.